Search Result: gene

IVT-circRNA・RNA-tLNP: LNP Surface Modification Efficiency >95%Learn moreNOW OPEN: Our Flagship Cell & Gene

and VEGFR would activate luciferase reporter gene expression.

for mAb and bsAbDownload(2351kb)Cell Line Development and Commercial LicenseDownload(2949kb)Cell and Gene

It is a milestone on the path to industrialization of the cell and gene therapy industry, pioneered by

AAV vector is the most widely used vehicle in delivering gene of interest (GOI) in in vivo gene therapies.ProBio

We will be able to meet the rapidly evolving demands of gene, cell, antibody and protein therapies.

synthesis to Top 6 clones14 weeks from gene synthesis to Top 1 clone Excellent DeliverablesAntibody

trials, and has successfully delivered a number of CMC and GMP production projects.ProBio 's integrated gene

The demand for viral vectors is rapidly increasing due to the recent growth of the gene therapy market

expedited timeline, good Ab sequence diversity and better cost-effectiveness.Case Study: TIGIT RGA Reporter Gene